FibroBiologics, Inc. Common StockFBLGNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank80
3Y CAGR+12.8%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+12.8%/yr
Quarterly compound
Percentile
P80
Within normal range
vs 3Y Ago
1.4x
Solid growth
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 20.37% |
| Q3 2025 | 0.30% |
| Q2 2025 | 24.47% |
| Q1 2025 | -71.66% |
| Q4 2024 | -17.92% |
| Q3 2024 | -33.85% |
| Q2 2024 | 54.46% |
| Q1 2024 | -167.02% |
| Q4 2023 | -40.56% |
| Q3 2023 | 29.91% |
| Q2 2023 | 20.19% |
| Q1 2023 | -73.57% |
| Q4 2022 | 14.19% |
| Q3 2022 | -179061.21% |
| Q2 2022 | 0.00% |
| Q1 2022 | 0.00% |